Consensus MorphoSys AG Deutsche Boerse AG

Equities

MOR

DE0006632003

Market Closed - Deutsche Boerse AG Other stock markets 07:29:58 03/07/2024 pm IST			Pre-market 11:02:01 am
67.3 ^EUR	-0.44%		67.62	+0.48%

26/06	European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	MT
24/06	INDEX-MONITOR: Tui, Rational and Traton in the MDax - Douglas moves up to the SDax	DP

Evolution of the average Target Price on MorphoSys AG

Price target over the last 5 years

History of analyst recommendation changes

01cff8b0d2c650e027923ac4.VyPgtuauUp4FdT9AeCjzjz9Silcld5m3xJooG7bKWXU.HWeGwrH6f-YoInkBAh2K1QZ_zw1dEPL1huIefvqdKDRhfKTArupi-H04fg~c62e308f68307e98eebd77583092f90a

Analyst Recommendations on MorphoSys AG

MORPHOSYS : UBS reiterates its Neutral rating	06/05	ZD
MORPHOSYS : UBS remains Neutral	30/04	ZD
Trending : Novartis Begins Tender Offer for MorphoSys Shares	12/04	DJ
MORPHOSYS : UBS sticks Neutral	16/02	ZD
MORPHOSYS : UBS revises his opinion and turns to Neutral	08/02	ZD
MORPHOSYS : UBS remains its Buy rating	07/02	ZD
MORPHOSYS : UBS reiterates its Buy rating	06/02	ZD
MORPHOSYS : JP Morgan reaffirms its Buy rating	06/02	ZD
MORPHOSYS : UBS reiterates its Buy rating	05/02	ZD
MORPHOSYS : Deutsche Bank sticks Neutral	31/01	ZD
MORPHOSYS : JP Morgan gives a Buy rating	30/01	ZD
UBS reiterates Morphosys at 'Buy' - Target 47 euros	30/01	DP
MORPHOSYS : UBS remains its Buy rating	30/01	ZD
MORPHOSYS : UBS reiterates its Buy rating	29/01	ZD
MORPHOSYS : JP Morgan reiterates its Buy rating	15/01	ZD
MORPHOSYS : Receives a Buy rating from JP Morgan	02/01	ZD
MORPHOSYS : Gets a Neutral rating from Goldman Sachs	19/12	ZD
Wells Fargo Adjusts MorphoSys' Price Target to $17 From $10, Keeps Overweight Rating	15/12	MT
MORPHOSYS : Deutsche Bank reiterates its Neutral rating	15/12	ZD
MORPHOSYS : JP Morgan gives a Buy rating	14/12	ZD
MORPHOSYS : Goldman Sachs sticks Neutral	12/12	ZD
MORPHOSYS : UBS gives a Buy rating	12/12	ZD
JPMorgan rates Morphosys at 'Overweight' - Target 31 euros	11/12	DP
MORPHOSYS : JP Morgan reiterates its Buy rating	11/12	ZD
UBS rates Morphosys a 'Buy' - Target 47 euros	11/12	DP

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

67.6 EUR

Average target price

58.71 EUR

Spread / Average Target

-13.14%

High Price Target

68 EUR

Spread / Highest target

+0.59%

Low Price Target

31 EUR

Spread / Lowest Target

-54.14%

Consensus detail

Consensus revision (last 18 months)

Analysts covering MorphoSys AG

UBS
JPMORGAN	James Gordon
DEUTSCHE BANK RESEARCH	Emmanuel Papadakis
GOLDMAN SACHS	Rajan Sharma
Wells Fargo Securities
JPMorgan Chase
MORGAN STANLEY	James Quigley
BERENBERG	Xian Deng
DEUTSCHE BANK	Rajan Sharma
BARCLAYS	Brian Balchin
Deutsche Bank Securities
Commerzbank
STIFEL	Marcus Wieprecht
SVB Leerink
Bryan, Garnier & Co.
INDEPENDENT RESEARCH	Tobias Gottschalt
RBC	Charles Weston
HSBC	Julie Mead

Ratings for MorphoSys AG

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar